About usSign in
Status
ACTIVE
Global HQ
San Francisco, United States
Countries of investment
  • Australia
  • United Kingdom
  • USA
Investment stages
  • Pre-Seed
  • Seed
  • Series A
Industries
  • Fintech
  • Blockchain
  • Crypto
  • Internet
  • Cybersecurity
About
AmorChem is a venture Capital firm focused on creating nextgeneration biotech companies. Since 2011, AmorChem has accelerated the creation of several companies, all originating from University research. They leverage academic entrepreneurship and their expertise in fundamental science to uncover therapeutic potential and drive therapeutic drug discovery and development. Their core strengths lie in translational research, which they use to accelerate the creation of startup companies that have the potential to become leading biotech companies. AmorChem aims to be the leader in early stage venture Capital funds in Canada, building an active and collaborative Community of BioTech companies emerging from University research while supporting a new generation of life science entrepreneurs.
Min check size
$250K
Max check size
$3M
Fund size
NPS

Investment Thesis

AmorChem is a leading early stage venture Capital fund dedicated to creating a new generation of BioTech companies, from University research to innovative biotech startups. They leverage academic entrepreneurship to generate Sustainable health and Theyalth and focus on translational research to accelerate therapeutic drug discovery and development across a broad spectrum of disease areas.
Lead investor
Co Invest
Number of exits
Preferred contact method

Portfolio

Oligo Factory

Eligo Bioscience

Inversago Pharma

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp